Search
for
Sort by
Research 241–270 of 1000+
- Understanding Polycystic Ovary Syndrome
- Hair loss after covid 19 - case series
- General Dermatology
- The PDGF/PDGFR pathway as a drug target
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Use of chemotherapy during human pregnancy
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- The Rotterdam Study: 2016 objectives and design update
- Leucine-Rich Repeat-Containing G-Protein-Coupled Receptors as Markers of Adult Stem Cells
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Vitamin D metabolism and function in the skin
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Dermatological adverse events with taxane chemotherapy
- Vitamin D and the skin: Focus on a complex relationship: A review
- Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Selenoproteins Are Essential for Proper Keratinocyte Function and Skin Development
- Beyond acne: Current aspects of sebaceous gland biology and function
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Clinical and biological impact of the exposome on the skin
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Endocrine Influences on Hair Growth
- Management of congenital ichthyoses: European guidelines of care, part two